Unique ID issued by UMIN | UMIN000048420 |
---|---|
Receipt number | R000055117 |
Scientific Title | Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway |
Date of disclosure of the study information | 2022/08/01 |
Last modified on | 2024/01/21 09:49:44 |
Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway
Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway
Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway
Pathophysiology of bronchopulmonary dysplasia focusing on the IL-33 pathway
Japan |
Bronchopulmonary dysplasia
Pediatrics |
Others
NO
To determine the relationship between the IL-33 pathway and bronchopulmonary dysplasia in preterm infants.
Others
To clarify the role of cytokines such as IL-6, IL-8, VEGF, and TNF-alpha in the acute phase as biomarkers of bronchopulmonary dysplasia.
Exploratory
Others
Not applicable
Serum IL-33 concentration at corrected 36 weeks
IL-33 pathway IL-4, IL-5, IL-13, TSLP at corrected 36 weeks; IL-6, IL-8, VEGF, TNF-alpha and other cytokines in the acute phase.
Observational
1 | days-old | <= |
4 | months-old | >= |
Male and Female
Preterm infants born at less than 30 weeks gestation requiring ventilatory support such as ventilatory mechanical ventilation, continuous positive airway pressure, high flow nasal cannula etc.
congenital multiple malformation syndrome, chromosome abnormalities, congenital airway malformations
110
1st name | Maki |
Middle name | |
Last name | Urushihara |
Tokushima University Hospital
Department of pediaircs
770-8503
Kuramotocho-3chome 18-15, Tokushima City
+81-88-633-7135
urushihara@tokushima-u.ac.jp
1st name | Kenichi |
Middle name | |
Last name | Suga |
Tokushima University Hospital
Department of pediatrics
770-8503
Kuramotocho-3chome 18-15, Tokushima City
+81-88-633-7135
suga.kenichi.1@tokushima-u.ac.jp
Tokushima University Hospital
Tokushima University Hospital
Self funding
the Ethics Committee of Tokushima University Hospital
Kuramotocho-3chome 18-15, Tokushima City
+81-88-633-9294
awachiken@tokushima-u.ac.jp
NO
香川大学(香川県)高知大学(高知県)愛媛大学(愛媛県)
四国こどもとおとなの医療センター(香川県)高知医療センター(高知県)
愛媛県立中央病院(愛媛県)
2022 | Year | 08 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2022 | Year | 07 | Month | 20 | Day |
2022 | Year | 09 | Month | 28 | Day |
2022 | Year | 09 | Month | 01 | Day |
2024 | Year | 03 | Month | 31 | Day |
-mail c-akiyoshi-shin@eph.pref.ehime.jp
The purpose of this study is to clarify the association between the development of bronchopulmonary dysplasia in preterm infants and cytokines in the IL-33 pathway. In a collaborative study with major NICU facilities in Shikoku, we will compare serum IL-33 concentrations at corrected 36 weeks between groups of preterm infants requiring respiratory support who are born at less than 30 weeks' gestation and those who does not develop chronic lung disease as the primary endpoint. The secondary endpoint will be the IL-33 pathway including IL-4, IL-5, IL-13, and TSLP at 36 weeks by multiplex assay. Cytokines such as IL-6, IL-8, VEGF, and TNF-alpha in the acute phase will also be examined as biomarkers of bronchopulmonary dysplasia . If the relationship between IL-33 pathway and bronchopulmonary dysplasia is clarified by this study, IL-33 antibody (Itepekimab) and IL-4/13 antibody (Dupilumab) targeting IL-33 pathway may be candidates for treatment and may improve the prognosis of bronchopulmonary dysplasia .
2022 | Year | 07 | Month | 21 | Day |
2024 | Year | 01 | Month | 21 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000055117
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |